| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $414,900,683 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG014190 | Niche Trajectory Analysis of Spatial Omics Data | 000 | 1 | NIH | 4/17/2026 | $2,583,834 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI194793 | Evaluating Differences in Innate Immune Response to Highly Pathogenic H5N1 Viruses | 001 | 2 | NIH | 8/13/2026 | $52,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33DA056779 | Cue Reactivity Modulation in Methamphetamine Use Disorder | 000 | 3 | NIH | 3/19/2026 | $834,725 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG097202 | Clonal hematopoiesis, epigenetic changes, social determinants of health, and behavioral risk factors as predictors of accelerated aging in HIV | 000 | 2 | NIH | 7/31/2026 | $689,827 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK143032 | Modulating Iron Trafficking to Ameliorate Ineffective Erythropoiesis in MDS | 000 | 1 | NIH | 2/18/2026 | $871,028 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1MH139952 | Moderate effect size genes in autism spectrum disorder | 000 | 2 | NIH | 5/11/2026 | $3,252,932 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA303558 | Function and Therapeutic Implications of NRG3 in Breast Cancer Brain Metastasis | 000 | 1 | NIH | 5/7/2026 | $642,242 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R24ES036007 | The Ghana Randomized Air Pollution and Health Study (GRAPHS) Cohort | 000 | 3 | NIH | 4/8/2026 | $327,404 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03DK147337 | Targeting ChREBPbeta to Protect beta-Cells from Metabolic and Inflammatory Stress in Type 1 Diabetes | 000 | 1 | NIH | 5/11/2026 | $168,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AI194739 | Hepatocytes and skeletal myocytes shape immunity to mRNA-LNP encoded protein | 000 | 2 | NIH | 8/18/2026 | $55,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99ES037024 | Endocrine-Disrupting Chemical (EDC) Mixtures in Relation to Metabolic Syndrome (MetS) and Metabolomic Mechanisms in a Prospective Cohort of Hispanic Women | 000 | 2 | NIH | 8/10/2026 | $126,809 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01MH139990 | Projection-specific mechanisms mediating postpartum stress effects on the maternal brain | 000 | 1 | NIH | 3/19/2026 | $717,688 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG095776 | Role of m6A RNA Modifications in Microglial Dysfunction and Alzheimer's Disease Pathogenesis | 000 | 2 | NIH | 6/3/2026 | $839,933 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31DA066110 | The role of a novel cortical circuit in opioid reward | 001 | 1 | NIH | 4/9/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31DA066110 | The role of a novel cortical circuit in opioid reward | 000 | 1 | NIH | 4/9/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS150462 | Quantifying Biomechanical and Perfusion Abnormalities in Drug-Resistant Epilepsy: Novel MR Imaging Markers of Seizure Foci and Underlying Gliosis | 000 | 1 | NIH | 8/14/2026 | $646,706 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA066665 | Oligonucleotide delivery to treat cocaine use disorder | 000 | 1 | NIH | 7/24/2026 | $720,691 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA318242 | Functional determinants of disseminated tumor cell dormancy in the brain | 000 | 1 | NIH | 7/31/2026 | $712,912 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23HL186285 | Sleep restriction therapy for co-morbid insomnia and sleep apnea: An endotype-enriched pilot trial | 000 | 1 | NIH | 8/3/2026 | $193,467 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI199768 | Efficacy of a Broadly Neutralizing Monoclonal Antibody Against Mpox in Non-Human Primates | 000 | 1 | NIH | 7/17/2026 | $781,563 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | P01HL187164 | Elucidating the contributions of genetic variation to congenital heart disease causality and outcomes | 000 | 1 | NIH | 8/20/2026 | $3,095,910 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31HL184602 | Investigating Protein Complexes in the Interferon System | 001 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31HL184602 | Investigating Protein Complexes in the Interferon System | 000 | 1 | NIH | 4/10/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM162572 | Molecular mechanisms of gating and selectivity in the MscS and MRS2 superfamilies of channels | 000 | 1 | NIH | 8/11/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES038499 | Chemical Mixture Exposures in Early Life: Impacts on Executive Function and Neural Circuitry Across Adolescence | 000 | 1 | NIH | 6/23/2026 | $815,546 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33HL185498 | A streamlined base editor reengineering platform to enhance gene editing specificity and selectivity | 000 | 1 | NIH | 6/23/2026 | $570,666 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH140323 | Characterization of splicing and isoform dysregulation in ASD at cellular resolution | 000 | 1 | NIH | 8/20/2026 | $763,265 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI191344 | Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics | 000 | 1 | NIH | 3/30/2026 | $475,339 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23AG093224 | Exposure to incarceration among community-dwelling older adults: effects on health, mechanisms, and sources of resilience | 000 | 1 | NIH | 8/4/2026 | $165,509 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32HG014400 | A framework to characterize monogenic disease in founder populations using biobank-scale data | 000 | 1 | NIH | 4/27/2026 | $76,300 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99DA065809 | Dopamine receptor type 2 (D2)-expressing cells in the ventral hippocampus controlrelapse behavior | 000 | 1 | NIH | 4/21/2026 | $181,092 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01HL186236 | Causal Machine Learning and Trial Emulation for Precision Cardiovascular Risk Stratification in Obstructive Sleep Apnea (CLARITY-OSA) | 000 | 1 | NIH | 6/25/2026 | $170,892 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99ES039036 | Environmental Mixtures of Phenols and Phthalates and Their Interconnection with Child Neurobehavior and Obesity | 000 | 1 | NIH | 7/31/2026 | $127,710 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA299197 | Role of ATAD2 in Prostate Cancer Progression and Metastasis | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA299197 | Role of ATAD2 in Prostate Cancer Progression and Metastasis | 000 | 1 | NIH | 4/21/2026 | $682,886 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL182870 | Investigating how lifestyles selectively modify clonal hematopoiesis in atherosclerosis through immuno-metabolic reprogramming | 000 | 1 | NIH | 8/4/2026 | $839,536 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UH3AG083258 | Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans | 001 | 4 | NIH | 8/12/2026 | $1,244,248 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM166361 | Spatial Principles of Nuclear RNA Organization | 000 | 1 | NIH | 7/24/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA310749 | Improved Lung Cancer Screening Approaches for People Living with HIV | 000 | 1 | NIH | 6/23/2026 | $711,272 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21MH144609 | Mechanistic Dissection of SRRM2-Mediated RNA Splicing and Subnuclear RNA Organization in Human Neurons | 000 | 1 | NIH | 8/18/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 002 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI203004 | Molecular Mechanisms of Pararubulavirus Entry and Fusion Activation | 001 | 1 | NIH | 8/10/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI202288 | Fate-Mapping and Genetic Dissection of B-to-T Feedback Circuits Shaping Germinal-Center Selection | 000 | 1 | NIH | 8/7/2026 | $210,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 002 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI203004 | Molecular Mechanisms of Pararubulavirus Entry and Fusion Activation | 000 | 1 | NIH | 8/10/2026 | $49,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA317126 | Elucidating novel functions of ATRX in-frame fusion proteins in neuroblastoma | 000 | 1 | NIH | 7/16/2026 | $431,970 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 000 | 1 | NIH | 3/24/2026 | $400,000 |
|
